DEC 06, 2019 11:30 AM PST

Federal Restrictions Make It Hard For Cannabis Researchers

WRITTEN BY: C Reardon

With marijuana use becoming more popular in aiding health, scientists race to find clarity around its health benefits and risks. Since the legalization of medical marijuana, available science has been lacking. Providers are unable to counsel patience in this area with the proper science backing. 

In the United States, over 22 million people are consuming cannabis products without the scientific understanding around what the potential risks or benefits may be. Currently, legislatures are still identifying what health conditions can legally be aided by medical marijuana, but often without dependable evidence.

This is concerning considering that cannabis-related emergency room visits have increased, and the cannabis market is projected to triple in the next five years. We must grow our understanding of this drug as quickly as possible.

What stands in the way of solid scientific research? The tight federal restrictions around cannabis research in the United States. To date, researchers are limited to just a few varieties of cannabis compounds, which is certainly not a reflection of the wide range available to consumers. Under federal law, marijuana is classified as a Schedule I controlled substance, which means it is considered to have low medicinal value, with high addictive qualities. The Drug Enforcement Administration (DEA) believes that there is not enough evidence to change its classification. Still, under this classification, it is hard for researchers to do thorough research due to restrictions.

Photo Source: Pixabay.com

Researchers can be fined or face criminal penalties if they do not follow the strict guidelines and rules set in place by the DEA in regards to cannabis research. 

The Association of American Medical Colleges says that a change in classification from a Substance I to a Substance III would be beneficial for cannabis research. They also suggested that the DEA allow for the expansion of growers, as well as the number of varieties that they produce for research. They say that these varieties “need to be varieties that can be inhaled, ingested, or applied to the skin.”

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
DEC 29, 2020
Immunology
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
DEC 29, 2020
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
Viruses that when administered to patients preferentially attack and kill cancer cells, leaving normal tissues unscathed ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
JAN 03, 2021
Genetics & Genomics
Exploiting Genetic Vulnerabilities in Cancer Cells
JAN 03, 2021
Exploiting Genetic Vulnerabilities in Cancer Cells
Genetic errors can drive cancer, often when critical genes like those that control cell division and proliferation becom ...
JAN 03, 2021
Cannabis Sciences
Cannabis Users Don't Understand Health Risks of Smoking, Study Finds
JAN 03, 2021
Cannabis Users Don't Understand Health Risks of Smoking, Study Finds
A recent study has found that cannabis users often classify themselves as 'non-smokers' even though they smoke c ...
JAN 17, 2021
Immunology
A Single Dose Nanoparticle Vaccine for COVID-19
JAN 17, 2021
A Single Dose Nanoparticle Vaccine for COVID-19
In the race for finding the right vaccine for the COVID-19 pandemic, a new vaccine candidate emerged. Researchers at Sta ...
JAN 20, 2021
Microbiology
Cannabis Compound Could Lead to New Class of Antibiotics
JAN 20, 2021
Cannabis Compound Could Lead to New Class of Antibiotics
For the first time, a synthetic version of a non-psychoactive molecule found in marijuana has been shown to kill pathoge ...
Loading Comments...